WARNING! Daily COVID-19 Infections, Hospitalizations And Deaths Rising In United Kingdom And Elsewhere In Europe!

Source: SARS-CoV-2 Research  Aug 19, 2021  1 year ago
Breaking! University of Sao Paulo Study Alarmingly Reveals That SARS-CoV-2 Induces ER-Stress-Activated Unfolded Protein Reaction Resulting In Cell Death!
Breaking! University of Sao Paulo Study Alarmingly Reveals That SARS-CoV-2 Induces ER-Stress-Activated Unfolded Protein Reaction Resulting In Cell Death!
Source: SARS-CoV-2 Research  Aug 19, 2021  1 year ago
A new study by researchers from the University of Sao Paulo-Brazil has alarmingly revealed that the SARS-CoV-2 coronavirus is able to cause ER (Endosplasmic Reticulum)-stress-activated unfolded protein response that results in the cell death.

The study findings provide evidence that SARS-CoV-2 hijacks the glycosylation biosynthetic, ER-stress and UPR (unfolded protein response) machineries for viral replication as the study team had utilized a time-resolved (0-48 hours post infection, hpi) total, membrane as well as glycoproteome mapping and orthogonal validation strategy.
The study team found that SARS-CoV-2 induces ER stress and UPR is observed in Vero and Calu-3 cell lines with activation of the PERK-eIF2α-ATF4-CHOP signaling pathway. ER-associated protein upregulation was detected in lung biopsies of COVID-19 patients and associated with survival. At later time points, cell death mechanisms are triggered.
The study data shows that ER stress and UPR pathways are required for SARS-CoV-2 infection, therefore representing a potential target to develop/implement anti-CoVID-19 drugs.
The study findings were published on a preprint server and are currently being peer reviewed. https://www.biorxiv.org/content/10.1101/2021.06.21.449284v1
The ongoing COVID-19 pandemic has spurred intense interest into the mechanisms of cell damage and tissue death following infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The study findings describes the varying ways in which the virus co-opts the machinery of the host cell following infection to evade or modulate the host immune response, alter the pattern of translation of viral proteins, and the release of new viral particles.
It was found that among the most important changes that result from SARS-CoV-2 infection are the use of protein synthetic organelles and pathways to produce viral proteins and their post-translational modification by breaking up proteins, creating new disulfide bridges, adding phosphate groups, and especially, glycosylation.
It must be noted that Thailand Medical News had been stressing since the early part of the pandemic that attention has to be paid to the various viral proteins produced by the virus during replication as many of these viral proteins can still cause damage in the long term while they exists in the human hosts even after there has been viral clearance or so called ‘recovery’.
It should also be noted that glycosylation refers to the trafficking of newly synthesized viral proteins through the endoplasmic reticulum (ER) and Golgi apparatus, where glycans are added to them, especially N-linked glycans. The level of glycosylation and protein folding is regulated within these organelles.
Importantly this type of processing is often used to escape the host immune response by preventing virus recognition by the host; to enhance virus-receptor binding; increase viral infectivity and release from the cell; and increase virulence as well as promote virion release.
Hence targeting this makes it an obvious and important therapeutic antiviral solution.
As an example, if glycoprotein folding is disrupted by inhibiting N-linked glycosylation, or simply if the level of glycosylation is directly altered, SARS-CoV-2 infection could be targeted.
Significantly, unregulated viral protein synthesis by the hijacked cell machinery may rapidly exceed the capacity of the ER to fold proteins properly. The high level of unfolded proteins induces ER stress, which in turn triggers compensatory pathways called the unfolded protein response (UPR).
Typically viral proteins are glycosylated, particularly the SARS-CoV-2 spike protein at up to 35% of its composition. This affects the infectivity and susceptibility to immune neutralization.
However ER and Golgi compartment processing allows the cell to inhibit glycosylation, and perhaps suppress maturation, thus regulating virion assembly.
It was also found that the SARS-CoV-2 ORF8 (open reading frame 8) protein of the virus also interacts with several ER proteins, interfering with interferon-I release and thereby hampering antiviral immunity.
Important to also take note of is the fact that the result of UPR is negative feedback on protein synthesis, enhanced ER folding capacity, and diversion of misfolded proteins to be broken down within proteasomes.
The effects of UPR comprise three signaling pathways initiated by the three protein sensors IRE1, PERK and ATF6.
It is known that IRE1 activation results in the upregulation of genes involved in the ER stress response, while PERK activation results in phosphorylation. This, in turn, activates other transcriptional factors that lead to ATF4 expression at higher levels. The result is to reduce protein synthesis while inducing some other UPR-related transcription factors.
Interestingly ATF6 release from the ER membrane is followed by cleavage within the Golgi apparatus. The activated form enhances the expression of ER chaperone-encoding genes and other genes required for the breakdown of the unfolded proteins.
The study team found upon combining analysis of the complete protein profile of the infected host cell with that of microsomal proteins and deglycosylated proteins that SARS-CoV-2 indeed induces stress on the ER leading to a UPR along with a reduction in glycosylation within the host cell.
Alarmingly it was found that these responses were already occurring at 2 hours post-infection (hpi), indicating that the host glycoproteins were undergoing remodeling. The majority of proteins in the host proteome were downregulated at 48 hpi, while viral proteins increased dramatically in abundance, reflecting viral replication.
It was also found that conversely, apoptosis-related proteins such as cleaved caspase-3 were higher, with increased rates of protein folding, at this point or even earlier. Oxidative stress markers were also increased, despite an early rise in anti-oxidant activity in the infected cell. All cell lines did not show equal rates of apoptosis, however, indicating that they enter these cell signaling pathways at different rates. This could be because the host cell simultaneously activates enhanced homeostatic responses to remain viable.
Importantly the UPR was also confirmed to be due to viral infection, mediated by ER stress in these cells. Apoptosis is due to this pathway, as well as by NRF2-mediated signaling.
Hence, infection reduced protein synthesis at all-time points, except for an early increase at 6 hpi.
These study findings reflect those of earlier studies indicating that virus-induced activation of the UPR pathways enhances the expression of ER chaperones, thus facilitating infection. ER stress activates apoptosis pathways and may also cause increased oxidative stress by reactive oxygen species, mediated by pro-oxidant cytokines such as tumor necrosis factor (TNF).
Importantly the eventual outcome is cell death at a later stage of infection, at 48 hpi.
Hospitalized individuals with severe complicated COVID-19 show ER stress markers such as phosphorylated PERK in their lung tissue. This also occurs in kidney and liver cells. The higher the ER transcriptional level, the longer the survival of the patient.
Corresponding author, Professor Dr Giuseppe Palmisano, from the Glycoproteomics Laboratory, Department of Parasitology, ICB, University of São Paulo, told Thailand Medical News, “These study findings highlight the importance of ER-stress and UPR modulation as a host regulatory mechanism during viral infection and could point to novel therapeutic targets.”
For the latest SARS-CoV-2 Research, keep on logging to Thailand Medical News.


Aug 13, 2020  2 years ago
Source: Supplements For COVID-19
Feb 05, 2020  3 years ago
Source : Thailand Medical news